Fukuda Denshi CoFKDSF 83 Days Payable is 63.57 as of Mar. 2026, which is 25% below its 10-year median of 85.31. GuruFocus rates FKDSF with a GF Score™ of 83/100 and a GF Value™ of $27.75. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Fukuda Denshi Co ranks worse than 50.57% on this metric.
The historical rank and industry rank for Fukuda Denshi Co's Days Payable or its related term are showing as below:
FKDSF'
s Days Payable Range Over the Past 10 Years
Min: 64.47 Med: 85.31 Max: 104.7
Current: 67.66
During the past 13 years, Fukuda Denshi Co's highest Days Payable was 104.70. The lowest was 64.47. And the median was 85.31.
FKDSF's Days Payable is ranked worse than 50.57% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FKDSF: 67.66
Fukuda Denshi Co's Days Payable
increased
from Mar. 2025 (60.69) to Mar. 2026 (63.57).
It may suggest that Fukuda Denshi Codelayed paying its suppliers.
Fukuda Denshi Co Days Payable Related Terms
Fukuda Denshi Co Days Payable Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Fukuda Denshi Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Fukuda Denshi Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (FKDSF) has a Days Payable of 63.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fukuda Denshi Co and its competitors. This is 25% below median its historical median of 85.31. Over the past decade, Fukuda Denshi Co's Days Payable has ranged from 64.47 to 104.70. According to the industry distribution chart, Fukuda Denshi Co ranks #402 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 50.6%.
Is Fukuda Denshi Co's Days Payable too high?
Fukuda Denshi Co's current Days Payable of 63.57 is 25% below median its 10-year median of 85.31. Over the past 10 years, this metric has ranged from a low of 64.47 to a high of 104.70. The Medical Devices & Instruments industry median Days Payable is 68.07. Fukuda Denshi Co's value of 63.57 is 6.6% below this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #402 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #402 out of 795 companies for Days Payable. This places Fukuda Denshi Co in the lower half of its industry. The industry median Days Payable is 68.07. Fukuda Denshi Co's value of 63.57 is 6.6% below this benchmark. Historically, Fukuda Denshi Co's own Days Payable has ranged from 64.47 to 104.70 over the past decade. While the company's 10-year median is 85.31 vs. the industry median of 68.07, Fukuda Denshi Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current Days Payable of 63.57 is 6.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current Days Payable is 63.57, which is 25% below median its own 10-year median of 85.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Fukuda Denshi Co (FKDSF) has a current Days Payable of 63.57. The stock's GF Value™ is $27.75, compared to a current price of $42.55 — trading 53.3% above its estimated fair value. The current Days Payable is 63.57, which is 25% below median its 10-year median of 85.31 and 6.6% below the Medical Devices & Instruments industry median of 68.07. Fukuda Denshi Co's overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Fukuda Denshi Co (FKDSF), the current Days Payable is 63.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of $42.55 is trading 53.3% above its estimated GF Value™ of $27.75.
Key valuation signals for FKDSF:
Days Payable: 63.57 (25% below median its 10-year median of 85.31)
GF Value™: $27.75 vs. price of $42.55 (53.3% above fair value)
Industry Position: 6.6% below the Medical Devices & Instruments median (#402 of 795)
No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for FKDSF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FKDSF has been successfully added to your 
